| AD | Alzheimer’s disease |
| ADME | Absorption, metabolism, distribution, and excretion |
| AMPK | 5′ adenosine monophosphate-activated protein kinase |
| ARE | Antioxidant response element |
| ATF6 | Activating transcription factor 6 |
| Aβ | Amyloid-beta |
| BDNF | Brain-derived neurotrophic factor |
| CA | Carnosic acid |
| CNF | Central nervous system |
| CVD | Cardiovascular diseases |
| D3T | 1,2-dithiole-3-thione |
| DMF | Dimethyl fumarate |
| DS | Down syndrome |
| ER | Endoplasmic reticulum |
| HGPS | Hutchinson–Gilford progeria syndrome |
| HSE | Heat-shock factor response elements |
| HSF1 | Heat shock transcription factor 1 |
| HSP | Heat shock proteins |
| HUVEC | Human umbilical vein EC |
| I/R | Ischemia-reperfusion |
| IIS | Insulin/IGF1 signaling |
| IR | Insulin resistance |
| IRE1 | Inositol-requiring protein 1 |
| LDL | Low-density lipoprotein (LDL) |
| MetS | Metabolic syndrome |
| mHtt | Mutant huntingtin protein |
| mTOR | mammalian target of rapamycin |
| NAC | N-Acetylcysteine |
| NFTs | Neurofibrillary tangles |
| NRF2 | Nuclear factor erythroid 2-related factor 2 |
| OS | Oxidative stress |
| PBMCs | Peripheral blood mononuclear cells |
| PDI | Protein disulfide isomerase |
| PEDs | Pro-electrophilic drugs |
| PERK | PKR-like ER kinase |
| PINK1 | PTEN-induced putative kinase 1 |
| PPI | Protein–protein interaction |
| ROS | Reactive oxygen species |
| RosA | Rosmarinic acid |
| SFN | Sulforaphane |
| SKN-1 | Skinhead-1 |
| T2D | Type 2 diabetes mellitus |
| UPR | Unfolded protein response |
| UPS | Ubiquitin-proteasome system |